Evidence map›Paper›PMID 42902134›Full record

ArticleBMC plant biology2026

CRK5 preserves antioxidant homeostasis and prevents cell death during dark-induced senescence through inhibiting the salicylic acid signaling pathway.

Muhammad Kamran, Paweł Burdiak, Anna Rusaczonek, Roshanak Zarrin Ghalami, Stanisław M Karpiński

Abstract read
In one paragraph

Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Muhammad KamranDepartment of Plant Genetics, Breeding and Biotechnology, Institute of Biology, Warsaw University of Life Sciences, Nowoursynowska Street 159, Warsaw, 02-776, Poland.
Paweł BurdiakDepartment of Plant Genetics, Breeding and Biotechnology, Institute of Biology, Warsaw University of Life Sciences, Nowoursynowska Street 159, Warsaw, 02-776, Poland.
Anna RusaczonekDepartment of Botany and Plant Physiology, Institute of Biology, Warsaw University of Life Sciences, Nowoursynowska 159, Warsaw, 02-776, Poland.
Roshanak Zarrin GhalamiDepartment of Plant Genetics, Breeding and Biotechnology, Institute of Biology, Warsaw University of Life Sciences, Nowoursynowska Street 159, Warsaw, 02-776, Poland.
Stanisław M KarpińskiDepartment of Plant Genetics, Breeding and Biotechnology, Institute of Biology, Warsaw University of Life Sciences, Nowoursynowska Street 159, Warsaw, 02-776, Poland. karpinskistanislaw@gmail.com.

Funding

Narodowe Centrum Nauki Opus 20 UMO 2020/39/B/NZ3/02103
6 · The paper itself

Abstract

backgroundDark-induced senescence (DIS) is a widely used model for dissecting the regulatory mechanisms that manage leaf aging, redox imbalance, and cell death (CD) in plants. Salicylic acid (SA) is a central hormonal regulator of these processes. However, the mechanism involving upstream components, which integrate SA-dependent pathways with antioxidant homeostasis during DIS, remains unresolved. CYSTEINE-RICH RECEPTOR-LIKE KINASE 5 (CRK5) is a membrane-localized protein that plays a role in developmental and stress-responsive pathways. Its promoter contains multiple W-box cis-elements, indicating regulation by WRKY factors in SA-mediated pathways. This study investigates how CRK5 modulates SA-dependent CD and antioxidant dynamics during DIS.

resultsIn this study, SA-accumulating mutant crk5 exhibited accelerated senescence, elevated electrolyte leakage, enhanced micro-lesion formation, and markedly increased reactive oxygen species (ROS) accumulation under both control and dark conditions. These phenotypes were accompanied by a substantial reduction in carotenoid and xanthophyll pools, enhanced accumulation of phenolic compounds, and increased free radical scavenging capacity, including ascorbate peroxidase, catalase, and superoxide dismutase activities. Importantly, crk5 phenotype was fully reverted in crk5sid2 and crk5NahG double mutants, confirming that crk5 DIS phenotype is induced by activation of the SA signaling pathway. Transcriptome profiling revealed extensive deregulation of senescence-, CD-, and redox-associated genes in crk5 during darkness, including strong induction of SAGs, metacaspases, autophagy, and antioxidant-related transcripts. The line with constitutively enhanced SA level (cpr1), used as a control, showed similar phenotypes to crk5, although transcriptional reprogramming was largely absent in cpr1 after darkness, highlighting CRK5 as a key upstream negative regulator of SA-mediated CD and positive regulator of antioxidant homeostasis.

conclusionOur work presents CRK5 as a central regulatory hub that inhibits the SA signaling, ROS burst, and CD activation during DIS. Loss of CRK5 function is associated with the activation of SA signaling, altered antioxidant systems, increased ROS burden, and ROS-driven CD acceleration, resulting in accelerated senescence. Conversely, suppression of SA-biosynthesis or catabolism in a crk5 background restores the wild-type phenotype. These findings position this receptor kinase as a key mediator that coordinates hormonal, metabolic, and oxidative pathways to maintain leaf viability, providing mechanistic insight into the control of stress-induced senescence and CD in Arabidopsis (Arabidopsis thaliana).

Indexed as

AntioxidantsArabidopsisArabidopsis ProteinsPlant SenescenceSalicylic AcidCell DeathDarknessGene Expression Regulation, PlantHomeostasisPlant LeavesReactive Oxygen SpeciesSignal TransductionAntioxidantsArabidopsis ProteinsReactive Oxygen SpeciesSalicylic AcidAntioxidant systemCell deathDark-induced senescenceReactive oxygen speciesReceptor-like kinaseSalicylic acid

Identifiers

PMID42902134
PMCPMC13685261

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.